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Summarv 
Adult male Swiss-kebster mice were implanted with permanently inawelling 
cannul ae with tips within the lateral cerebral ventricle. The neuropeptide 
dynorphin was infused centrally and subjects were tested on a variety of 
behavioral tasks. Peptide treated mice were more likely than vehicle treated 
mice to eat and groom. At higher doses, dynorphin treated mice showed barrel 
rotation which was occasionally succeeded by death. Effects upon behavior 
were only partially reversible by naloxone. 
introduction 
Dynorphin is a recently isolated and partially identified neurohypo- 
physeal peptide IGoldstein, Tachibana, Lowney, Hunkapiller and Hood, 1979). 
It is of particular interest because it may be the normal biological precursor 
for Leu-enkephalin, and may itself possess biological activity. At present 
its actions in vivo are not well established, although preliminary reports 
indicate potential roles in catalepsy and analgesia (op. cit.). 
ke report herein a number of effects suggesting the compound may be 
broadly involved in the regulation of motivation and behavior. Our results 
also suggest at least some of these effects are unrelated to classic opiate 
receptor stimulation. 
Materals and Methods 
Adult male Swiss-kebster mice (30 k j g) were surgically prepared with 
permanently indwelling cannulae as described in detail in previous reports 
(Katz, Carroll and tialdrighi, 1978). briefly, a single 23 ga. stainless steel 
needle was stereotaxically implanted within the lateral ventricle based on 
co-orainates (-2.2, -1, -2.2 mm) from Slotnick and Leonard (1975). The 
cannula was anchored to the skull with three O-b0 stainless steel screws and 
acrylic dental cement. One week of recovery was allowed before testing with 
vehicle or drug. Dynorphin (Peninsula Laboratories, San Carlos, Calif.) was 
prepared fresh in polypropylene containers and injected intracerebroventric- 
ularly 0, 25, and 50 pg, in 5 ~1 of 0.9% sodium chloride vehicle. ke have 
found this injection volume to produce few effects upon behavior (Katz et al., 
1976). lime between preparation of the solution and injection was 20 set or 
less, and injections were completed with an infusion time of less than 20 sec. 
Mice were observed in 51 x 41 x 22 cm polypropylene cages (Scientific 
Products, Series 70) to which they had been extensively (96 h) habituated in 
12 previous sessions. Four hours placement in the cages immediately preceded 
injections and observations. 
A bedding of fresh pine chips was placed on the cage floor and five food 
pellets (Teklad 4.0% fat diet s-0836) were scattered randomly throughout the 
cage. Behaviors were observed five, ten, fifteen, and twenty minutes after 
injection for one minute periods, and rated on a presence/absence scale. The 
following categories of behavior uere rated: forward locomotion, grooming and 
eating. Scores of ratings were summed within categories to produce a 
behavioral score ranging f’rom 0 to 4. For example, a mouse observed to be 
feeding in each of the observation periods would have a net feeding score of 
4.0. 
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Results 
Vehicle injections produced no remarkable changes in behavior although 
some forward locomotion was present for the initial 10 minutes. Peptide 
injected mice at the lower dose showed consistent feeding and grooming. ‘Ihe 
higher dose produced violent barrel rotation in half the mice tested, and this 
was followed by substantial (50%) mortality within 60 minutes of injection. 
Results are presentc:d in ‘Iable Gne. Naloxone reversibility is considered a 
criterion of pharmacological specificity for opiate effects, and a separate 
group of mice was pretreated with naloxone hC1 (4.0 lag/kg int r.X!>eritoneally 
ten minutes prior to central injection; control mice received 0.9% sodium 
chloride vehicle pretreatment). It may further be seen in ‘Iable One that 
blockade by naloxone had only slight effect upon the behavioral effects of 
dynorphin. It should be noted that naloxone was tested against 25 pg of 
pept ide except for the case of barrel rotation. A higher dose of peptide was 
required to elicit the rotational syndrome itself. Upon statistical analysis, 
the reductions proved no different than dynorphin effects. It allould be noted 
this is a behaviorally active dose of naloxone against opiates of various 
classes in other tests (Katz et al., 197b; Stein and Belluzzi, 197U). From 
this analysis it is evident that dynorphin possesses behavioral activity in 
vivo and that this may at least partly be dissociated from the occupation of 
opiate receptors. histological examination ten minutes following injection of 
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Discussion 
The findings are of interest in identifying some possible roles for 
dynorphin in behavioral regulation. ‘Ihe fact that the arug elicits feeding 
and grooming is consistent with a view of endorphins as “satisfiers” as 
proposed by Stein and colleagues (1978). lhe present results indicate only 
partial naloxone reversibility for grooming and feeding. It must be 
considered that partial reversibility may indicate certain behavioral 
functions extrinsic to opiate receptors, and this indeed would extend Stein’s 
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